1 Min Read
* Nabriva Therapeutics announces proposed public offering of ordinary shares
* Nabriva Therapeutics Plc says has commenced an underwritten public offering of $80.0 million of ordinary shares. Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.